Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients.
Saved in:
| Title: | Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients. |
|---|---|
| Authors: | Correale P; Translational Immuno-Oncology Unit, Medical Oncology Section, Department G. Segre of Pharmacology, Siena University School of Medicine, Siena, Italy., Remondo C, Carbone SF, Ricci V, Migali C, Martellucci I, Licchetta A, Addeo R, Volterrani L, Gotti G, Rotundo MS, Tassone P, Sperlongano P, Abbruzzese A, Caraglia M, Tagliaferri P, Francini G |
| Source: | Cancer biology & therapy [Cancer Biol Ther] 2010 May 01; Vol. 9 (9), pp. 685-93. |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20697196 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Correale+P%22">Correale P</searchLink>; Translational Immuno-Oncology Unit, Medical Oncology Section, Department G. Segre of Pharmacology, Siena University School of Medicine, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Remondo+C%22">Remondo C</searchLink><br /><searchLink fieldCode="AU" term="%22Carbone+SF%22">Carbone SF</searchLink><br /><searchLink fieldCode="AU" term="%22Ricci+V%22">Ricci V</searchLink><br /><searchLink fieldCode="AU" term="%22Migali+C%22">Migali C</searchLink><br /><searchLink fieldCode="AU" term="%22Martellucci+I%22">Martellucci I</searchLink><br /><searchLink fieldCode="AU" term="%22Licchetta+A%22">Licchetta A</searchLink><br /><searchLink fieldCode="AU" term="%22Addeo+R%22">Addeo R</searchLink><br /><searchLink fieldCode="AU" term="%22Volterrani+L%22">Volterrani L</searchLink><br /><searchLink fieldCode="AU" term="%22Gotti+G%22">Gotti G</searchLink><br /><searchLink fieldCode="AU" term="%22Rotundo+MS%22">Rotundo MS</searchLink><br /><searchLink fieldCode="AU" term="%22Tassone+P%22">Tassone P</searchLink><br /><searchLink fieldCode="AU" term="%22Sperlongano+P%22">Sperlongano P</searchLink><br /><searchLink fieldCode="AU" term="%22Abbruzzese+A%22">Abbruzzese A</searchLink><br /><searchLink fieldCode="AU" term="%22Caraglia+M%22">Caraglia M</searchLink><br /><searchLink fieldCode="AU" term="%22Tagliaferri+P%22">Tagliaferri P</searchLink><br /><searchLink fieldCode="AU" term="%22Francini+G%22">Francini G</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101137842%22">Cancer biology & therapy</searchLink> [Cancer Biol Ther] 2010 May 01; Vol. 9 (9), pp. 685-93. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101137842 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1555-8576 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215384047%22">15384047 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Biol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20697196 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4161/cbt.9.9.11441 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 685 Titles: – TitleFull: Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Correale P – PersonEntity: Name: NameFull: Remondo C – PersonEntity: Name: NameFull: Carbone SF – PersonEntity: Name: NameFull: Ricci V – PersonEntity: Name: NameFull: Migali C – PersonEntity: Name: NameFull: Martellucci I – PersonEntity: Name: NameFull: Licchetta A – PersonEntity: Name: NameFull: Addeo R – PersonEntity: Name: NameFull: Volterrani L – PersonEntity: Name: NameFull: Gotti G – PersonEntity: Name: NameFull: Rotundo MS – PersonEntity: Name: NameFull: Tassone P – PersonEntity: Name: NameFull: Sperlongano P – PersonEntity: Name: NameFull: Abbruzzese A – PersonEntity: Name: NameFull: Caraglia M – PersonEntity: Name: NameFull: Tagliaferri P – PersonEntity: Name: NameFull: Francini G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2010 May 01 Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1555-8576 Numbering: – Type: volume Value: 9 – Type: issue Value: 9 Titles: – TitleFull: Cancer biology & therapy Type: main |
| ResultId | 1 |
